Company News
Halozyme COO Departs, Stock Down 3.1%
Halozyme Therapeutics disclosed that Senior Vice President and Chief Operating Officer Cortney Caudill will exit the company effective June 30, 2026.
Halozyme shares dropped 3.1% in after‑hours tradin
